|
1.
|
Doorbar J: Molecular biology of human
papillomavirus infection and cervical cancer. Clin Sci.
110:525–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Madkan VK, Cook-Norris RH, Steadman MC,
Arora A, Mendoza N and Tyring SK: The oncogenic potential of human
papillomaviruses: a review on the role of host genetics and
environmental cofactors. Br J Dermatol. 157:228–241. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Samani AA, Yakar S, LeRoith D and Brodt P:
The role of the IGF system in cancer growth and metastasis:
overview and recent insights. Endocr Rev. 28:20–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Cohen P: Overview of the IGF-I system.
Horm Res. 65(Suppl 1): 3–8. 2006. View Article : Google Scholar
|
|
5.
|
Pollak M: Insulin and insulin-like growth
factor signalling in neoplasia. Nat Rev Cancer. 8:915–928. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Mittanck DW, Kim SW and Rotwein P:
Essential promoter elements are located within the 5′ untranslated
region of human insulin-like growth factor-I exon I. Mol Cell
Endocrinol. 126:153–163. 1997.
|
|
7.
|
Wierstra I: Sp1: emerging roles – beyond
constitutive activation of TATA-less housekeeping genes. Biochem
Biophys Res Commun. 372:1–13. 2008.
|
|
8.
|
LeRoith D and Roberts CT Jr: The
insulin-like growth factor system and cancer. Cancer Lett.
195:127–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Musarò A, Dobrowolny G and Rosenthal N:
The neuroprotective effects of a locally acting IGF-1 isoform. Exp
Gerontol. 42:76–80. 2007.PubMed/NCBI
|
|
10.
|
Gee SL, Aoyagi K, Lersch R, Hou V, Wu M
and Conboy JG: Alternative splicing of protein 4.1R exon 16:
ordered excision of flanking introns ensures proper splice site
choice. Blood. 95:692–699. 2000.PubMed/NCBI
|
|
11.
|
Baraniak AP, Chen JR and Garcia-Blanco A:
Fox-2 mediates epithelial cell-specific fibroblast growth factor
receptor 2 exon choice. Mol Cell Biol. 26:1209–1222. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zhang C, Zhang Z, Castle J, Sun S, Jahnson
J, Krainer AR and Zhang MQ: Defining the regulatory network of the
tissue-specific splicing factors FOX-1 and FOX-2. Genes Dev.
22:2550–2563. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Jozefiak A, Pacholska-Bogalska J,
Myga-Nowak M, Kedzia W, Kwasniewska A, Luczak M, Kedzia H and
Gozdzicka-Jozefiak A: Serum and tissue levels of insulin-like
growth factor-I in women with dysplasia and HPV-positive cervical
cancer. Mol Med Rep. 1:231–237. 2008.PubMed/NCBI
|
|
14.
|
Serrano ML, Sánchez-Gómez M and Bravo MM:
Insulin-like growth factor system gene expression in cervical
scrapes from women with squamous intraepithelial lesions and
cervical cancer. Growth Horm IGF Res. 17:492–499. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Tan DS, Cook A and Chew SL: Nucleolar
localization of an isoform of the IGF-I precursor. BMC Cell Biol.
3:172002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tavassoli FA and Deville P; World Health
Organization Classification of Tumors: Pathology, Genetics. Tumours
of the Breast and Female Genital Organs. IRAC Press; Lyon: 2003
|
|
17.
|
Kosary CL: FIGO stage, histology,
histologic grade, age and race as prognostic factors in determining
survival for cancers of the female gynecological system: an
analysis of 1973–87 SEER cases of cancers of the endometrium,
cervix, ovary, vulva, and vagina. Semin Surg Oncol. 10:31–46.
1994.PubMed/NCBI
|
|
18.
|
Manos MM, Ting Y, Wright DK, Lewis AI,
Broker TR and Wolinsky SM: The use of polymerase chain reaction
amplification for the detection of genital human papillomaviruses.
Cancer Cells. 7:209–214. 1989.
|
|
19.
|
Daud II and Scott ME: Validation of
reference genes in cervical cell samples from human
papillomavirus-infected and -uninfected women for quantitative
reverse transcription-PCR assays. Clin Vaccine Immunol.
15:1369–1373. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Philippou A, Papageorgiou E, Bogdanis G,
Halapas A, Sourla A, Maridaki M, Pissimissis N and Koutsilieris M:
Expression of IGF-1 isoforms after exercise-induced muscle damage
in humans: characterization of the MGF E peptide actions in vitro.
In Vivo. 23:567–575. 2009.PubMed/NCBI
|
|
21.
|
Matheny RW, Nindl BC and Adamo MI:
Mechano-growth factor: a putative product of IGF 1 gene expression
involved in tissue repair and regeneration. Endocrinology.
151:3865–3875. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Barton ER: The ABC of IGF 1 isoforms:
impact on muscle hypertrophy and implication for repair. Appl
Physiol Nutr Metab. 31:791–797. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Górecki DC, Beręsewicz M and Zabłocka B:
Neuroprotective effects of short peptides derived from the
insulin-like growth factor 1. Neurochem Int. 51:451–458.
2007.PubMed/NCBI
|
|
24.
|
Vinciquerra M, Santini MP, Claycomb WC,
Ladurner AG and Rosenthal N: Local-IGF-1 isoform protects
cardiomyocytes from hypertrophic and oxidative stresses via Sirt1
activity. Aging (Albany NY). 43–62. 2010.PubMed/NCBI
|
|
25.
|
Ohtsuki T, Otsuki M, Murakami Y, Maekowa
T, Yamamoto T, Kasaka K, Takenchi S and Takahashi S: Organ-specific
and age-dependent expression of insulin-like growth factor-I
(IGF-I) mRNA variants: IGF-IA and IB mRNAs in the mouse. Zoolog
Sci. 22:1011–1021. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Pfeffer LA, Brisson BK, Lei H and Barton
ER: The insulin-like growth factor (IGF)-I E-peptides modulate cell
entry of the mature IGF-I protein. Mol Biol Cell. 20:3810–3817.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Bell I, Martin A and Roberts S: The E1^E4
protein of human papillomavirus interacts with the
serine-arginine-specific protein kinase SRPK1. J Virol.
81:5437–5448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Bodaghi S, Jia R and Zheng ZM: Human
papillomavirus type 16 E2 and E6 are RNA-binding proteins and
inhibit in vitro splicing of pre-mRNAs with suboptimal splice
sites. Virology. 386:32–43. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Cheunim T, Zhang J, Milligan SG,
McPhillips MG and Graham SV: The alternative splicing factor hnRNP
A1 is up-regulated during virus-infected epithelial cell
differentiation and binds the human papillomavirus type 16 late
regulatory element. Virus Res. 131:189–198. 2008. View Article : Google Scholar
|
|
30.
|
Mole S, McFarlane M, Chuen-Im T, Milligan
SG, Millan D and Graham SV: RNA splicing factors regulated by HPV16
during cervical tumour progression. J Pathol. 219:383–391. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Venables JP, Klinck R, Koh C, et al:
Cancer-associated regulation of alternative splicing. Nat Struct
Mol Biol. 16:670–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Li T, Chen YH, Liu TJ, Jia J, Hampson S,
Shan YX, Kibler D and Wang PH: Using DNA microarray to identify Sp1
as a transcriptional regulatory element of insulin-like growth
factor 1 in cardiac muscle cells. Circ Res. 93:1202–1209. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Gloss B and Bernard HU: The E6/E7 promoter
of human papillomavirus type 16 is activated in the absence of E2
proteins by a sequence-aberrant Sp1 distal element. J Virol.
64:5577–5584. 1990.PubMed/NCBI
|
|
34.
|
McPhillips MG, Veerapraditsin T, Cumming
SA, Karali D, Milligan SG, Boner W, Morgan IM and Graham SV:
SF2/ASF binds the human papillomavirus type 16 late RNA control
element and is regulated during differentiation of virus-infected
epithelial cells. J Virol. 78:10598–10605. 2004. View Article : Google Scholar
|
|
35.
|
Li B, Wang X, Zhou F, Saunders NA, Frazer
IH and Zhao KN: Up-regulated expression of Sp1 protein coincident
with a viral protein in human and mouse differentiating
keratinocytes may act as a cell differentiation marker.
Differentiation. 76:1068–1080. 2008. View Article : Google Scholar
|
|
36.
|
Carboni JM, Lee AV, Hadsell DL, et al:
Tumor development by transgenic expression of a constitutively
active insulin-like growth factor I receptor. Cancer Res.
65:3781–3787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Linnerth NM, Siwicky MD, Campbell CI,
Watson KL, Petrik JJ, Whitsett JA and Moorehead RA: Type I
insulin-like growth factor receptor induces pulmonary
tumorigenesis. Neoplasia. 11:672–682. 2009.PubMed/NCBI
|
|
38.
|
Chong YM, Colston K, Jiang WG, Sharma AK
and Mokbel K: The relationship between the insulin-like growth
factor-1 system and the oestrogen metabolising enzymes in breast
cancer tissue and its adjacent non-cancerous tissue. Breast Cancer
Res Treat. 99:275–288. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Weber MM, Fottner C, Liu SB, Jung MC,
Engelhardt D and Baretton GB: Overexpression of the insulin-like
growth factor I receptor in human colon carcinomas. Cancer.
95:2086–2095. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Werner H, Shalita-Chesner M, Abramovitch
S, Idelman G, Shaharabani-Gargir L and Glaser T: Regulation of the
insulin-like growth factor-I receptor gene by oncogenes and
antioncogenes: implications in human cancer. Mol Genet Metab.
71:315–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Kuramoto H, Hongo A, Liu Y, Ojima Y,
Nahamura K, Seki N, Kodama J and Hiramatsu Y: Immunohistochemical
evaluation of insulin-like growth factor 1, receptor status in
cervical cancer specimens. Acta Medica Okayama. 62:251–259.
2008.PubMed/NCBI
|
